Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry
- PMID: 28104069
- DOI: 10.1016/j.jacc.2016.10.062
Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry
Erratum in
-
Correction.J Am Coll Cardiol. 2017 Feb 28;69(8):1102. doi: 10.1016/j.jacc.2017.01.007. J Am Coll Cardiol. 2017. PMID: 28231941 No abstract available.
Abstract
Background: Clinical trials of implantable cardioverter-defibrillators (ICDs) for secondary prevention of sudden cardiac death were conducted nearly 2 decades ago and enrolled few older patients.
Objectives: This study assessed morbidity and mortality of older patients receiving ICDs for secondary prevention in contemporary clinical practice.
Methods: We identified 12,420 Medicare beneficiaries from the National Cardiovascular Data Registry ICD Registry undergoing first-time secondary prevention ICD implantation between 2006 and 2009 in 956 U.S. hospitals. Risks of death, hospitalization, and admission to a skilled nursing facility (SNF) were assessed over 2 years in age strata (65 to 69, 70 to 74, 75 to 79, and ≥80 years of age) using Medicare claims. The adjusted association between age and outcomes was evaluated using multivariable models.
Results: The mean age was 75 years at the time of implantation; 25.3% were <70 years of age and 25.7% were ≥80 years of age. Overall, the risk of death at 2 years was 21.8%, ranging from 14.7% among those <70 years of age to 28.9% among those ≥80 years of age (adjusted risk ratio [aRR]: 2.01; 95% confidence interval [CI]: 1.85 to 2.33; p for trend <0.001). The cumulative incidence of hospitalizations was 65.4%, ranging from 60.5% in those <70 years of age to 71.5% in those ≥80 years of age (aRR: 1.27; 95% CI: 1.19 to 1.36; p for trend <0.001). The cumulative incidence of admission to a SNF ranged from 13.1% among those <70 years of age to 31.9% among those ≥80 years of age (aRR: 2.67; 95% CI: 2.37 to 3.01; p for trend <0.001); SNF admission risk was highest in the first 30 days.
Conclusions: Almost 4 in 5 older patients receiving a secondary prevention ICD survives at least 2 years. High hospitalization and SNF admission rates, particularly among the oldest patients, identify substantial care needs after device implantation.
Keywords: arrhythmia; elderly; electrophysiology.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
The Conundrum of Defibrillators in the Elderly.J Am Coll Cardiol. 2017 Jan 24;69(3):275-277. doi: 10.1016/j.jacc.2016.10.063. J Am Coll Cardiol. 2017. PMID: 28104070 No abstract available.
Similar articles
-
Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry.JACC Clin Electrophysiol. 2017 Jan;3(1):20-28. doi: 10.1016/j.jacep.2016.06.001. Epub 2016 Sep 7. JACC Clin Electrophysiol. 2017. PMID: 29759690
-
Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.BMJ. 2015 Jul 14;351:h3529. doi: 10.1136/bmj.h3529. BMJ. 2015. PMID: 26174233 Free PMC article.
-
Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.Circulation. 2014 Sep 2;130(10):845-53. doi: 10.1161/CIRCULATIONAHA.114.008653. Epub 2014 Aug 5. Circulation. 2014. PMID: 25095884
-
Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26. PMID: 25356453 Free Books & Documents. Review.
-
Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.Europace. 2014 Jan;16(1):55-62. doi: 10.1093/europace/eut277. Epub 2013 Sep 20. Europace. 2014. PMID: 24058182 Review.
Cited by
-
Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients.Clin Cardiol. 2024 Feb;47(2):e24191. doi: 10.1002/clc.24191. Epub 2023 Nov 14. Clin Cardiol. 2024. PMID: 37964443 Free PMC article.
-
Association Between Industry Payments to Physicians and Device Selection in ICD Implantation.JAMA. 2020 Nov 3;324(17):1755-1764. doi: 10.1001/jama.2020.17436. JAMA. 2020. PMID: 33141208 Free PMC article.
-
Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter-Defibrillator Use.J Am Heart Assoc. 2020 Mar 3;9(5):e015139. doi: 10.1161/JAHA.119.015139. Epub 2020 Feb 24. J Am Heart Assoc. 2020. PMID: 32089058 Free PMC article. Review. No abstract available.
-
Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019.Arq Bras Cardiol. 2019 Jun 6;112(5):649-705. doi: 10.5935/abc.20190086. Arq Bras Cardiol. 2019. PMID: 31188969 Free PMC article. No abstract available.
-
Implantable Cardiac Electronic Devices in the Elderly Population.Arrhythm Electrophysiol Rev. 2019 May;8(2):143-146. doi: 10.15420/aer.2019.3.4. Arrhythm Electrophysiol Rev. 2019. PMID: 31114690 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
